Visit COVID-19 resources

[Skip to Content]

Serial evaluation of retinal vascular changes in infants treated with intravitreal bevacizumab for aggressive posterior retinopathy of prematurity in zone I – (Eye 30, 392 (March 2016))

10 March 2016

This news item is available to RCOphth members only, please log in below to access.

Members Login